Navigation Links
Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse

Prevalence of Alcohol Abuse Among ADHD Patients Nearly Triple That of General Population, Affecting Approximately 1 Million People

INDIANAPOLIS, May 23, 2007 /PRNewswire-FirstCall/ -- Data from a recent clinical study showed Strattera(R) (atomoxetine HCl) improved symptoms of Attention- Deficit/Hyperactivity Disorder (ADHD) in patients with comorbid alcohol abuse disorder, suggesting ADHD can be treated safely and effectively with Strattera in patients with both disorders. Results from the 12-week study were presented today at a major medical meeting of psychiatrists.

The study was designed to test the hypothesis that Strattera is superior to placebo in the treatment of ADHD symptoms and prevention of relapse of alcohol abuse in adult patients with both ADHD and comorbid alcohol abuse disorder who were recently abstinent.

"ADHD is present in at least one-quarter of adults with alcohol abuse or dependence. Treating ADHD in adults with co-occurring alcohol abuse can be challenging, and up until now, no data have been available to help us know how to treat these patients. Often the first course of action is to treat the alcohol problem first, then later the ADHD," said study author Timothy E. Wilens, M.D., director of substance abuse services in the Pediatric Psychopharmacology Clinics at Massachusetts General Hospital and associate professor of psychiatry at Harvard Medical School in Boston. "While additional studies are needed, this study is encouraging because it is the first to show that ADHD can be treated safely and effectively with Strattera in patients with ADHD and very recent alcohol abuse."

Results of the study of 147 adults who met full DSM-IV-TR (Diagnostic and Statistical Manual of Mental Disorders) criteria for ADHD and comorbid alcohol abuse, showed that Strattera was superior to placebo in the reduction of ADHD symptoms as measured by the ADHD Investigator Symptom Rating Scale
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:6/19/2013)... June 19, 2013 The Physician-Patient Alliance for Health ... The need to urgently address this issue has ... Event Alert #50 , "Medical device alarm safety in hospitals." ... January 2008 and June 2012, there were 98 alarm related ... death (82%) , 13 resulted in permanent loss of ...
(Date:6/19/2013)... June 19, 2013   BioCision , a ... and handling in many areas of medical and ... patents by the U.S. Patent Office that apply ... to standardize sample handling to ensure the consistency ... common laboratory procedures. Patent number ...
(Date:6/19/2013)... 19, 2013 ... DrugPatentWatch to its extensive list of ...      (Logo: http://photos.prnewswire.com/prnh/20130128/590935) , ... pharmaceutical, drug patents and their expirations. ... business functions of patent agents and ...
Breaking Medicine Technology:Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2Drug Patent Watch 2Drug Patent Watch 3
(Date:6/19/2013)... UT (PRWEB) June 19, 2013 ... , In July 2013, Orriant is launching a ... rates, and maintain compliance with regulations. New ... to receive wellness incentives if their employer offers ... they have been compliant with these standards for ...
(Date:6/19/2013)... Citi Bike has come to New York City in a ... know for sure how many patients will choose to take advantage ... option. In fact, he’s happy about anything that might help ... more convenient for them to visit his office at 133 East ... Medicine at Back and Body Medical and an experienced NYC ...
(Date:6/19/2013)... trauma surgery have had a significant impact on ... major injuries, including burns. Patients who survive ... at greatest risk from infections particularly the ... or from inflammation-induced multiorgan failure. Now, a ... that measures the movement of key immune cells ...
(Date:6/19/2013)... The results of three important studies have been published ... journal of the Congress of Neurological Surgeons . ... & Wilkins , a part of Wolters Kluwer ... learning" using artificial neural networks (ANNs) may improve the ... cancers. Another study in the June Neurosurgery ...
(Date:6/19/2013)... available in Spanish . ... diseases, it goes by the name of the 10/90 gap: ... to conditions that accounted for 90 per cent of the ... the Drugs for Neglected Diseases initiative (DNDi) came into being ... has been granted the BBVA Foundation Frontiers of Knowledge Award ...
Breaking Medicine News(10 mins):Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3Health News:Restoring appropriate movement to immune cells may save seriously burned patients 2Health News:Restoring appropriate movement to immune cells may save seriously burned patients 3Health News:Neurosurgery publishes findings of 3 important studies in June issue 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 3Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 2Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 3Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 4Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 5
... could be signs of flu. These days, people fear the symptoms ... wait in hours-long lines to get a shot of influenza vaccine ... panic. "We're getting a tremendous amount of calls and a tremendous ... County Health Department in upstate New York. "People are anxious to ...
... whether people with aches and coughs have the ominous first signs ... have runny noses. In general, the first symptoms of inhaled anthrax ... fever, ache, cough, no energy. // ,As a result, ... which do nothing for colds and flu -- just to make ...
... go to bed early to be ready for a big test ... study to be released Friday by a San Fernando Valley researcher ... // , REM sleep is a deep sleep during ... body is almost completely paralyzed except for the heart, diaphragm, eye ...
... time and improve performance for military servicemen who must perform ... periods of time, according to a new report by the ... of Medicine, found that 100 to 600 mg of caffeine, ... help "maintain cognitive performance," especially in times of sleep deprivation. ...
... American doctors, there is no upper age limit to the ... for detecting bowel cancer and polyps before any symptoms develop. ... a faecal occult blood test (FOBT), sigmoidoscopy or colonoscopy - ... a family history of colon cancer. // ,But it ...
... which may allow the early detection of all forms of ... a cholesterol test, the 'C-Test' will be evaluated in a ... is based on scientific work by the John Baskin's School ... Rodrigues Pat, leader of the research team, said the blood ...
Cached Medicine News:Health News:Detection of Cancer 2
... of three test plates(6mm, 3mm, and 1.5mm thick), ... of 600 - 15 seconds. No special glasses ... detected if stereopsis is present. Test plates can ... patient learning the correct answer. Large stereo acuity ...
8 X 1 Red Filter. Color Filters are designed to filter out all other color regions of the visible spectrum except the specified color. Color Filters are excellent for contrast enhancement and color r...
Last 3-6 months average refrigeration will prolong life. Pupil gauge printed on penlight 4 1/2" long 1/2" around....
Doctors six-pack long lasting, disposable, diagnostic penlights. Constant use time of 30 minutes. One year shelf life warranty from date of purchase. Convenient clip-activated switch & imprinted medi...
Medicine Products: